Exercise training reduces systemic inflammation and improves general health status in female migraineurs: a randomised controlled trail

Eur J Appl Physiol. 2024 May;124(5):1397-1408. doi: 10.1007/s00421-023-05371-5. Epub 2023 Dec 3.

Abstract

Objectives: The objectives of this study were to assess the effect of 8 weeks of moderate-intensity aerobic training on permeability inflammatory indicators of matrix metalloproteinases (MMPs) and specific tissue inhibitors of MMPs in female migraineurs.

Methods: Female migraineurs (n = 28, age 32 ± 6) were randomised into two groups: migraine with exercise training (EXE + Mig, n = 13) and migraine without exercise training (NON-EXE + Mig, n = 15). Matched healthy women were also recruited as a healthy control group (CON, n = 15). The EXE-Mig group performed 8 weeks of aerobic training. Pre and post intervention, serum matrix metalloproteinases (MMP-2 and 9) and specific tissue inhibitors of MMPs (TIMP-1 and 2) were measured. In addition, body composition indices and VO2max were determined.

Results: Exercise training reduced serum MMP-9 in female migraineurs with between-group changes and a time x group interaction (p < 0.05). In addition, exercise training reduced the serum MMP-9/TIMP-1 ratio in female migraineurs with between-group changes and time x group interaction (p < 0.05). However, no training-induced effect was observed in serum TIMP-1, TIMP-2, MMP-2 contents (p > 0.05) and MMP-2/TIMP-2 ratio (p > 0.05). Finally, exercise training reduced body fat content, WHR and BMI, and improved VO2max (p < 0.01).

Conclusions: Our results demonstrated beneficial effects of aerobic exercise training on some circulatory inflammation factors (MMP9, MMP-9/TIMP-1) and some health indicators in female migraineurs, suggesting that such training can be employed as a non-pharmacological therapeutic method.

Keywords: Aerobic training; Matrix metalloproteinases (MMP-2, 9); Migraine; Specific tissue inhibitors of MMPs (TIMP-1, 2); Women.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Exercise / physiology
  • Exercise Therapy* / methods
  • Female
  • Health Status
  • Humans
  • Inflammation* / blood
  • Matrix Metalloproteinase 2* / blood
  • Matrix Metalloproteinase 9 / blood
  • Migraine Disorders* / blood
  • Migraine Disorders* / physiopathology
  • Migraine Disorders* / therapy
  • Tissue Inhibitor of Metalloproteinase-1* / blood
  • Tissue Inhibitor of Metalloproteinase-2 / blood

Substances

  • Tissue Inhibitor of Metalloproteinase-1
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Tissue Inhibitor of Metalloproteinase-2
  • TIMP1 protein, human